Technologies for converting non-edible biomass into chemicals and fuels traditionally made from petroleum exist aplenty. But when it comes to attracting commercial interest, these technologies compete financially with a petroleum-based production pipeline that has been perfected over the course of decades.
A UW–Madison professor has formed a startup to advance a streamlined chip design that will run up to 10 times faster than those now inside data centers.
A UW–Madison spinoff called Isomark is working to introduce a new infection-detection technology into hospital intensive care units.
Propeller Health makes an add-on device for inhalers that communicates with a smartphone that records the use of routine preventative medicines and “rescue” medications intended to open constricted airways.
UW-Madison students Shane Lian and Colin Harris have created a journaling app called “Journalit.” Submitted photo UW–Madison student Colin Harris, a senior in …
Ensodata, a UW–Madison spinoff that sifts through mountains of data from studies at sleep centers, received approval from the Food and Drug Administration on April 11 for its main product to be a medical device.
In a bit of high-tech judo, a UW–Madison spinoff has started selling a technology to transform phosphorus at wastewater treatment plants from a major headache into an asset.
Two UW radiologists founded ImageMoverMD, a Middleton business that streamlines image processing in hospitals and clinics, and enables quick consultations between specialists.
Conveyor maker Nercon's leaders learned new productivity techniques from UW–Madison's Engineering Professional Development department.
A fledgling company that emerged from the UW–Madison College of Engineering applies high-speed genetic sequencing to the difficult problem of detecting — and for the first time counting — pathogens in water.
An idea hatched during an engineering class at the University of Wisconsin–Madison promises to reduce waste in a common industrial mixing process.
HealthDecision, LLC, a 7-year old startup with deep roots at the University of Wisconsin–Madison, has just released the fourth module in a series intended to help doctors and patients share decisions.
Endries International has made key advances with the help of the UW E-Business Consortium, a collaborative group of businesses founded in 1998 at the UW–Madison College of Engineering.
SHINE Medical Technologies, Inc. of Janesville has been awarded $10 million from the U.S. Department of Energy to advance production of an isotope used in cancer and heart diagnosis.
Fred Blattner has been doing DNA research for more than 50 years, and he founded or co-founded three successful companies all focused on DNA: DNASTAR, Nimblegen and Scarab Genomics.
James Steele’s new company, Lactic Solutions, is advancing a judo-like remedy: using genetic engineering to transform enemy into friend.
Shawn Michels, a UW–Madison student and diabetic, has invented an add-on to conventional insulin pens that allows users to make their injections with one hand.
Leaders of the University of Wisconsin–Madison lab that first transformed human stem cells into brain cells have started a company that produces and sells specialized neurons to drug researchers.
Success will take years, but if the noninvasive screening test works, it could aid in early detection of a cancer that kills about 26,000 American men every year.